Target
Egl nine homolog 1 [179-426]
Ligand
BDBM107716
Substrate
n/a
Meas. Tech.
EGLN-1 Activity Assay
IC50
2500±n/a nM
Citation
 Kawamoto, RMWu, SEvdokimov, AGGreis, KDBoyer, ASWarshakoon, NC Prolyl hydroxylase inhibitors and methods of use US Patent  US11426393 Publication Date 8/30/2022 
Target
Name:
Egl nine homolog 1 [179-426]
Synonyms:
C1orf12 | EGLN1 | EGLN1_HUMAN | Hypoxia-inducible factor prolyl hydroxylase 2 (HIFPH2)
Type:
n/a
Mol. Mass.:
27759.84
Organism:
Homo sapiens (Human)
Description:
EGLN-1-179/426
Residue:
248
Sequence:
LRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF
  
Inhibitor
Name:
BDBM107716
Synonyms:
US11426393, Compound Table XV.22 | US8598210, Table XV, 22 | US8722895, 22: ({3-Hydroxy-5-[3-(pyrrolidine-1-carbonyl)- phenyl]-pyridine-2-carbonyl}-amino)-acetic acid methyl ester | US9598370, Example 00147 | USRE47437, Example ({3-Hydroxy-5-[3-(pyrrolidine-1-carbonyl)-phenyl]-pyridine-2-carbonyl}-amino)-aceticacid methyl ester
Type:
Small organic molecule
Emp. Form.:
C20H21N3O5
Mol. Mass.:
383.3978
SMILES:
COC(=O)CNC(=O)c1ncc(cc1O)-c1cccc(c1)C(=O)N1CCCC1
Structure:
Search PDB for entries with ligand similarity: